FDA Seeks To Improve External Defibrillator Design, Manufacture
This article was originally published in The Gray Sheet
Executive Summary
FDA’s newest device improvement initiative targets another widely used, lifesaving device with a history of adverse events and recalls: external defibrillators used to treat sudden cardiac arrest.
You may also be interested in...
External Defibrillator Makers Seek Guidance On Reporting Adverse Events
Makers of external defibrillators to treat sudden cardiac arrest want better FDA guidance on when to report adverse events for the critical-use devices.
External Defibrillator Makers Seek Guidance On Reporting Adverse Events
Makers of external defibrillators to treat sudden cardiac arrest want better FDA guidance on when to report adverse events for the critical-use devices.
Technology Hazards Remain High, But Industry Can Help, ECRI Exec Says
The device industry should work more closely with hospitals, professional societies, FDA and others to combat the growing incidence of preventable medical errors that stem from the misuse of technologies, according to a non-profit hospital services group.